Soluble CD163, A Product of Monocyte/Macrophage Activation Is Significantly Lower In Maternal And Umblical Cord Serum In Women With Preeclampsia

Muneera  Abdalziz Alsheeha; Abdelmarouf  Hussan Moheldein; Maamun  Rgab; Eltuhami  Abdel-Magied; Ishag  Adam; Ishag  Adam

doi:10.52981/sjms.v11i3.1112

Muneera Abdalziz Alsheeha College of Medicine, Qassim University, Kingdom of Saudi Arabia
Abdelmarouf Hussan Moheldein College of Applied Medical Sciences, Qassim University, KSA
Maamun Rgab Maternity and Child Hospital, Qassim, KSA
Eltuhami Abdel-Magied College of Medicine, Qassim University, Kingdom of Saudi Arabia
Ishag Adam
Ishag Adam

DOI: https://doi.org/10.52981/sjms.v11i3.1112

Keywords: preeclampsia, Soluble CD163, macrophage, birth weight, Sudan

Abstract

Background: Although, the exact pathophysiology of preeclampsia is unknown, activation of monocytes and macrophages (monocyte/macrophage activation) is suggested to have a rolein the immunopathology of preeclampsia. Soluble CD163 (sCD163) is considered a specific marker of monocyte/macrophage activation. Nonetheless, investigations addressing sCD163 in cases preeclamptic women are needed.

Objectives: To investigate maternal and umbilical cord levels of sCD163 in women with preeclampsia.

Materials and Methods: A case – control study was conducted at the labour ward of Qassim Maternity Hospital, Kingdom of Saudi Arabia during the period of March -September 2015. Forty five cases of preeclamptic women and an equal number of healthy pregnant women were controls. Obstetrics and medical history was gathered using questionnaire. sCD163 levels were measured using ELISA.

Results: The two groups (45 in each arm of the study) were matched in their age and parity. Thirty- three of the 45 cases were patients with severe preeclampsia.
The median (interquartile) levels of both maternal [32.70(18.9 – 47.0) vs. 52.5(33.7–74.8)ng/ml, P= 0.001] and cord [12.30(10.9– 23.10) vs. 52.4(20.80 – 63.0) ng/ml, P< 0.001] sCD163 were significantly lower in the preeclamptic cases compared to the controls. There was a significant direct correlation between the maternal and umbilical cord level of sCD163. Both maternal and umbilical cord sCD163 levels were inversely correlated with birth weight.

Conclusion: The current study showed significantly lower maternal and cord sCD163 levels in women with preeclampsia as compared to controls. Moreover, there was a significant direct correlation between the maternal and umbilical cord level of sCD163 on one hand and birth weight on the other.

References

1. Duley Lelia. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009;33(3):130–7. Doi: 10.1053/j.semperi.2009.02.010.
2. Adam GK, Bakheit KH, Adam I. Maternal and perinatal outcomes of eclampsia in Gadarif Hospital, Sudan. J Obs Gynaecol 2009;29(7):619–20. Doi: 10.1080/01443610903150802.
3. Redman Christopher W, Sargent Ian L. Latest advances in understanding preeclampsia. Science 2005;308(5728):1592–4. Doi: 10.1126/science.1111726.
4. Walker JJ. Pre-eclampsia. Lancet (London, England) 2000;356(9237):1260–5. Doi: 10.1016/S0140-6736(00)02800-2.
5. Anderson UD, Olsson MG, Kristensen KH, Åkerström B, Hansson SR. Review: Biochemical markers to predict preeclampsia. Placenta 2012;33 Suppl:S42–7. Doi: 10.1016/j.placenta.2011.11.021.
6. Redman CWG, Sargent IL. Placental stress and pre-eclampsia: a revised view. Placenta 2009;30 Suppl A:S38–42. Doi: 10.1016/j.placenta.2008.11.021.
7. Roberts James M, Gammill Hilary S. Preeclampsia: recent insights. Hypertension 2005;46(6):1243–9. Doi: 10.1161/01.HYP.0000188408.49896.c5.
8. Böckle BC, Sölder E, Kind S, Romani N, Sepp NT. DC-sign+ CD163+ macrophages expressing hyaluronan receptor LYVE-1 are located within chorion villi of the placenta. Placenta 2008;29(2):187–92. Doi: 10.1016/j.placenta.2007.11.003.
9. Gustafsson Charlotte, Mjösberg Jenny, Matussek Andreas, Geffers Robert, Matthiesen Leif, Berg Göran, et al. Gene expression profiling of human decidual macrophages: evidence for immunosuppressive phenotype. PLoS One 2008;3(4):e2078. Doi: 10.1371/journal.pone.0002078.
10. Hunt Joan S. Stranger in a strange land. Immunol Rev 2006;213:36–47. Doi: 10.1111/j.1600-065X.2006.00436.x.
11. Huppertz Berthold. The feto-maternal interface: setting the stage for potential immune interactions. Semin Immunopathol 2007;29(2):83–94. Doi: 10.1007/s00281-007-0070-7.
12. Roberts JM, Hubel CA. Is oxidative stress the link in the two-stage model of pre-eclampsia? Lancet (London, England) 1999;354(9181):788–9. Doi: 10.1016/S0140-6736(99)80002-6.
13. Medeiros Leonardo TL, Peraçoli José C, Bannwart-Castro Camila F, Romão Mariana, Weel Ingrid C, Golim Marjorie A, et al. Monocytes from pregnant women with pre-eclampsia are polarized to a M1 phenotype. Am J Reprod Immunol 2014;72(1):5–13. Doi: 10.1111/aji.12222.
14. Medeiros LTL, Peracoli JC, Romao M,Bannwart-Castro CF, Golim MA, Borges VTM, et al. PP064. M1 Monocyte subpopulation is associated with pro-inflammatory cytokineproduction in pregnant women with preeclampsia. PregnancyHypertens 2012;2(3):276–7. Doi: 10.1016/j.preghy.2012.04.175.
15. Schonkeren Dorrith, van der Hoorn Marie-Louise, Khedoe Padmini, Swings Godelieve, van Beelen Els, Claas Frans, et al. Differential distribution and phenotype of decidual macrophages in preeclamptic versus control pregnancies. Am J Pathol 2011;178(2):709–17. Doi: 10.1016/j.ajpath.2010.10.011.
16. Kronborg Camilla S, Knudsen Ulla Breth, Moestrup Søren K, Allen Jim, Vittinghus Erik, Møller Holger J. Serum markers of macrophage activation in pre-eclampsia: no predictive value of soluble CD163 and neopterin. Acta Obstet Gynecol Scand 2007;86(9):1041–6. Doi: 10.1080/00016340701415236.
17. Gram Magnus, Anderson Ulrik Dolberg, Johansson Maria E, Edström-Hägerwall Anneli, Larsson Irene, Jälmby Maya, et al. The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators. PLoS One 2015;10(9):e0138111. Doi: 10.1371/journal.pone.0138111.
18. ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002;77(1):67–75.
19. Chua Caroline Lin Lin, Brown Graham V, Hamilton John A, Molyneux Malcolm E, Rogerson Stephen J, Boeuf Philippe. Soluble CD163, a product of monocyte/macrophage activation, is inversely associated with haemoglobin levels in placental malaria. PLoSOne 2013;8(5):e64127. Doi: 10.1371/journal.pone.0064127.
20. Van Gorp Hanne, Delputte Peter L, Nauwynck Hans J. Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy. Mol Immunol 2010;47(7-8):1650–60. Doi: 10.1016/j.molimm.2010.02.008.
21. Centlow Magnus, Carninci Piero, Nemeth Krisztian, Mezey Eva, Brownstein Michael, Hansson Stefan R. Placental expression profiling in preeclampsia: local overproduction of hemoglobin may drive pathological changes. Fertil Steril 2008;90(5):1834–43. Doi: 10.1016/j.fertnstert.2007.09.030.
22. Anderson Ulrik Dolberg, Olsson Magnus G, Rutardóttir Sigurbjörg, Centlow Magnus, Kristensen Karl Heby, Isberg Per Erik, et al. Fetal hemoglobin and Į1-microglobulin as first- and early second-trimester predictive biomarkers for preeclampsia. Am J Obstet Gynecol 2011;204(6):520.e1–5. Doi: 10.1016/j.ajog.2011.01.058.